ID   HCC149
AC   CVCL_V702
SY   HCC0149; Hamon Cancer Center 149
DR   BioSample; SAMN03470857
DR   Wikidata; Q54881576
RX   PubMed=25877200;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc and Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,14
ST   D12S391: 20
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 17,18
ST   D19S433: 15.2
ST   D1S1656: 14,15
ST   D21S11: 29,31.2
ST   D22S1045: 12
ST   D2S1338: 19,23
ST   D2S441: 10,14
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 10,11
ST   Penta E: 14 (Direct_author_submission)
ST   Penta E: 14,17 (PubMed=25877200)
ST   TH01: 7
ST   TPOX: 6
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=29681454; DOI=10.1016/j.cell.2018.03.028; PMCID=PMC5935540;
RA   McMillan E.A., Ryu M.-J., Diep C.H., Mendiratta S., Clemenceau J.R.,
RA   Vaden R.M., Kim J.-H., Motoyaji T., Covington K.R., Peyton M.,
RA   Huffman K., Wu X.-F., Girard L., Sung Y., Chen P.-H., Mallipeddi P.L.,
RA   Lee J.Y., Hanson J., Voruganti S., Yu Y., Park S., Sudderth J.,
RA   DeSevo C., Muzny D.M., Doddapaneni H., Gazdar A.F., Gibbs R.A.,
RA   Hwang T.H., Heymach J.V., Wistuba I.I., Coombes K.R., Williams N.S.,
RA   Wheeler D.A., MacMillan J.B., DeBerardinis R.J., Roth M.G.,
RA   Posner B.A., Minna J.D., Kim H.S., White M.A.;
RT   "Chemistry-first approach for nomination of personalized treatment in
RT   lung cancer.";
RL   Cell 173:864-878.e29(2018).
//
RX   PubMed=31803961; DOI=10.1002/jcb.29564; PMCID=PMC7496084;
RA   Mulshine J.L., Ujhazy P., Antman M., Burgess C.M., Kuzmin I.A.,
RA   Bunn P.A. Jr., Johnson B.E., Roth J.A., Pass H.I., Ross S.M.,
RA   Aldige C.R., Wistuba I.I., Minna J.D.;
RT   "From clinical specimens to human cancer preclinical models -- a journey
RT   the NCI-cell line database-25 years later.";
RL   J. Cell. Biochem. 121:3986-3999(2020).
//